BR-3005
- Generic Name
- BR-3005
A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fed Conditions in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Type2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT06289933
- Locations
- 🇰🇷
Clinical Research Center, H PLUS Yangji Hospital, Seoul, Gwanakgu, Korea, Republic of
A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3005" and Co-administration of "BR3005-1" and "BR3005-2" Under Fasting Conditions in Healthy Adult Volunteers
Phase 1
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- First Posted Date
- 2024-03-04
- Last Posted Date
- 2024-05-24
- Lead Sponsor
- Boryung Pharmaceutical Co., Ltd
- Target Recruit Count
- 47
- Registration Number
- NCT06289920
- Locations
- 🇰🇷
Clinical Research Center, H PLUS Yangji Hospital, Seoul, Gwanakgu, Korea, Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath